- Home
- DRCT vs CRIS Comparison
DRCT vs CRIS Comparison
Compare DRCT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- CRIS
- Stock Information
- Founded
- DRCT 2018
- CRIS 2000
- Country
- DRCT United States
- CRIS United States
- Employees
- DRCT N/A
- CRIS N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRCT Technology
- CRIS Health Care
- Exchange
- DRCT Nasdaq
- CRIS Nasdaq
- Market Cap
- DRCT 38.7M
- CRIS 32.8M
- IPO Year
- DRCT 2022
- CRIS 2000
- Fundamental
- Price
- DRCT $1.06
- CRIS $3.10
- Analyst Decision
- DRCT Strong Buy
- CRIS Strong Buy
- Analyst Count
- DRCT 3
- CRIS 3
- Target Price
- DRCT $21.00
- CRIS $23.00
- AVG Volume (30 Days)
- DRCT 267.3K
- CRIS 29.3K
- Earning Date
- DRCT 03-20-2025
- CRIS 03-04-2025
- Dividend Yield
- DRCT N/A
- CRIS N/A
- EPS Growth
- DRCT N/A
- CRIS N/A
- EPS
- DRCT N/A
- CRIS N/A
- Revenue
- DRCT $94,216,000.00
- CRIS $10,259,000.00
- Revenue This Year
- DRCT N/A
- CRIS N/A
- Revenue Next Year
- DRCT $37.23
- CRIS N/A
- P/E Ratio
- DRCT N/A
- CRIS N/A
- Revenue Growth
- DRCT N/A
- CRIS 0.44
- 52 Week Low
- DRCT $0.51
- CRIS $2.86
- 52 Week High
- DRCT $35.88
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- DRCT 41.45
- CRIS 41.55
- Support Level
- DRCT $1.10
- CRIS $3.10
- Resistance Level
- DRCT $1.18
- CRIS $3.32
- Average True Range (ATR)
- DRCT 0.08
- CRIS 0.18
- MACD
- DRCT 0.01
- CRIS -0.01
- Stochastic Oscillator
- DRCT 10.00
- CRIS 9.62
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.